Navigation Links
Global miRNA Market Outlook to 2018

NEW YORK, Dec. 24, 2013 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

Global miRNA Market Outlook to 2018

The recent discovery of miRNA and its wide applicability have sparked off a lot of interest among researchers as well as commercial players. Owing to the same, there are numerous clinical trials being organized all over the world in order to assess the potential of miRNA in diverse fields such as Cancer, Asthma, Heart disorders, Diabetes, Hepatitis etc. The report, "Global miRNA Market Outlook to 2018" provides an in-depth analysis of the various aspects of miRNA at the industry as well as the research front.

The market has been divided into three sections i.e., The Americas, Europe and Asia Pacific. These regions have then been analyzed to draw patterns in terms of research areas and applicability. A brief look at the market suggests that cancer is the most researched topic and regions such as United States, United Kingdom, France, Israel and China are the major players interested in evaluating the role played by miRNA.

Most of the current research is focused on utilizing miRNA for diagnostic purposes such as expression profiling, response evaluation and setting potential biomarkers in diseases. Another application is in the field of therapeutics where miRNA mimics and inhibitors are being applied to control gene translation and consequently its expression.

After an exhaustive study of the industry, RNCOS has laid out the primary market players. These players are working over a vast variety of products such as miRNA extraction and purification kits, and miRNA mimics and inhibitors. There are other players who are solely providing miRNA associated diagnostic services and assessing their therapeutic potential.

Overall, even though the market is in its nascent stage at the moment, it is expanding at an almost exponential rate. With new players entering the market, increase in the number of collaborations and strong support from research institutes, the miRNA market is bound to witness rampant diversification and growth in the coming years.

1. Analyst View

2. Research Methodology

3. miRNA - An Introduction

4. miRNA Techniques

4.1 miRNA Purification

4.2 miRNA Labeling

4.3 miRNA Linear Amplification

4.4 miRNA Microarrays

4.5 miRNA qRT-PCR

4.6 miRNA Inhibition

5. Global miRNA Market Outlook to 2018

5.1 By Geography

5.1.1 The Americas

5.1.2 Europe

5.1.3 Asia Pacific (APAC)

6. Ongoing miRNA Research by Disease

6.1 Cancer

6.2 Cardiovascular Diseases

6.3 Metabolic Diseases

6.4 Asthma

6.5 Hepatitis

7. Key Players

7.1 Mirna Therapeutics, Inc.

7.2 Rosetta Genomics, Ltd.

7.3 InteRNA Technologies B.V.

7.4 Santaris Pharma A/S

7.5 Regulus Therapeutics

7.6 miRagen Therapeutics

7.7 Qiagen

7.8 Sigma-Aldrich Corporation

7.9 Thermo Fisher Scientific Inc.

7.10 Agilent Technologies Inc.

7.11 Life Technologies Corporation

7.12 System Biosciences

7.13 GeneCopoeia


List of Figures:

Figure 3-1: miRNA Biogenesis

Figure 5-1: Global - miRNA Market (Million US$), 2012-2018

Figure 5-2: Ongoing miRNA Research by Geography (%), 2013

Figure 5-3: The Americas - miRNA Market (Million US$), 2012-2018

Figure 5-4: The Americas - Ongoing miRNA Research by Disease (%), 2013

Figure 5-5: Europe - miRNA Market (Million US$), 2012-2018

Figure 5-6: Europe - Ongoing miRNA Research by Disease (%), 2013

Figure 5-7: Europe - Ongoing miRNA Research by Country (%), 2013

Figure 5-8: APAC - miRNA Market (Million US$), 2012-2018

Figure 5-9: APAC - Ongoing miRNA Research by Disease (%), 2013

Figure 5-10: APAC - Ongoing miRNA Research by Country (%), 2013

Figure 6-1: Ongoing miRNA Research by Disease (%), 2013

Figure 6-2: Cancer - Ongoing miRNA Research (%), 2013


List of Tables:

Table 4-1: miRNA Purification Products by Supplier

Table 4-2: miRNA Labeling Products by Supplier

Table 4-3: miRNA Linear Amplification Products by Supplier

Table 4-4: miRNA Microarray Products by Supplier

Table 4-5: miRNA qRT-PCR Products by Supplier

Table 4-6: miRNA Inhibition Products by Supplier

Table 5-1: The Americas - Ongoing miRNA Research (2013)

Table 5-2: Europe - Ongoing miRNA Research (2013)

Table 5-3: APAC - Ongoing miRNA Research (2013)

Table 6-1: miRNAs associated with Cancer

Table 6-2: miRNA associated with Cardiovascular Diseases

Table 6-3: miRNAs associated with Metabolic Disorders

Table 6-4: miRNAs associated with Hepatitis

Table 7-1: Mirna Therapeutics - miRNA Research Pipeline

Table 7-2: Rosetta Genomics - miRNA based Cancer Tests

Table 7-3: InteRNA - miRNA Research Pipeline

Table 7-4: Santaris Pharma - miRNA Research Pipeline

Table 7-5: Regulus Therapeutics - miRNA Research Pipeline

Table 7-6: miRagen - miRNA Research Pipeline

Table 7-7: Qiagen - miRNA Associated Product Line

Table 7-8: Sigma Aldrich - miRNA Associated Product Line

Table 7-9: Thermo Fisher - miRNA Associated Product Line

Table 7-10: Agilent - miRNA Associated Product Line

Table 7-11: Life Technology - miRNA Associated Product Line

Table 7-12: System Biosciences - miRNA Associated Product Line

Table 7-13: GeneCopoeia - miRNA Associated Product Line


To order this report: Global miRNA Market Outlook to 2018

Contact Clare:
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
2. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
3. Global Cleantech Cluster Association Names New York City Startup Rentricity to Global Top 10 List
4. StemCyte Adds World Class Talent to its North America and Global Operations
5. Sequenom Named to NASDAQ Global Select Market
6. Synthetic Biology: Emerging Global Markets
7. MacroGenics Receives Milestone Payment as Part of Its Global DART™ Alliance with Boehringer Ingelheim
8. Amgen to Present at the 30th Annual J.P. Morgan Global Healthcare Conference
9. Hemodialysis Machine Industry 2012 Global & China Market Research Report - ReportsnReports
10. MarketsandMarkets: Global Seed Treatment Market worth $3430.3 Million by 2016
11. Accuray Surpasses 600 Installations Globally
Post Your Comments:
(Date:11/27/2015)... November 27, 2015 ... popularity of companion diagnostics is one of ... market with pharmaceutical companies and diagnostic manufacturers ... tests. . --> ... report on global cancer biomarkers market spread ...
(Date:11/25/2015)... -- PharmAthene, Inc. (NYSE MKT: PIP) announced  today that its ... (Rights Plan) in an effort to preserve the value ... 382 of the Internal Revenue Code (Code). ... its NOLs could be substantially limited if the Company ... of the Code. In general, an ownership change occurs ...
(Date:11/25/2015)... Nov. 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... President and CEO of Neurocrine Biosciences, will be presenting ... New York . ... website approximately 5 minutes prior to the presentation to ... the presentation will be available on the website approximately ...
(Date:11/25/2015)... PORTLAND, Oregon , November 25, 2015 /PRNewswire/ ... Deep Market Research Report is a professional and ... Genomics industry.      (Logo: ... basic overview of the industry including definitions, classifications, ... analysis is provided for the international markets including ...
Breaking Biology Technology:
(Date:11/18/2015)... York , November 18, 2015 ... Research has published a new market report titled  Gesture ... Trends, and Forecast, 2015 - 2021. According to the report, ... 2014 and is anticipated to reach US$29.1 bn by ... 2021. North America dominated ...
(Date:11/17/2015)... , November 17, 2015 ... au 19 novembre  2015.  --> Paris ... --> DERMALOG, le leader de l,innovation biométrique, ... la fois passeports et empreintes sur la même surface ... les passeports et l,autre pour les empreintes digitales. Désormais, ...
(Date:11/17/2015)... SOUTH EASTON, Mass. , Nov. 17, 2015 /PRNewswire/ ... "Company"), a leader in the development and sale of ... to the worldwide life sciences industry, today announced it ... closing of its $5 million Private Placement (the "Offering"), ... Offering to $4,025,000.  One or more additional closings are ...
Breaking Biology News(10 mins):